- Nov 28, 2019
A step forward in the struggle against neuroblastoma, a type of childhood cancer
A study published by experts from the University of Seville and IBiS shows that the protein CD44 can contribute to the aggressive behavior of cancerous mother cells and the appearance of metastasis. Read more: https://eurekalert.org/pub_releases/2019-11/uos-asf112719.php
- Nov 27, 2019
Tests suggest potential therapy for a childhood leukemia
New research in mice indicates a possible targeted therapy for a form of pediatric cancer, acute lymphoblastic leukemia. Read more: https://www.futurity.org/acute-lymphoblastic-leukemia-pediatric-cancer-all-2220612-2/
- Nov 26, 2019
Breakthrough in understanding common childhood cancer
"A study, led by experts at Newcastle University, UK, and published today in Clinical Cancer Research, has focussed on neuroblastoma cells which circulate in the blood and spread through the bone marrow. It is the first time that circulating neuroblastoma tumour cells have been identified in this way and experts say it is possible to test the effect of newer targeted types of treatments on the circulating tumour cells without the need for an invasive biopsy." Read more: https
- Nov 25, 2019
Two-Drug Combo Shows Promise in Treating Childhood Brain Cancers
Researchers have tested a new drug combination that shows promise for the treatment of several types of childhood brain cancers known as diffuse midline gliomas (DMG). Read more: https://www.biospace.com/article/new-hope-for-childhood-brain-cancers/
- Nov 14, 2019
Pediatric cancer can affect mental health of patients’ families long after initial diagnosis, study
Parents and siblings of children with cancer can struggle with anxiety, stress and other mental health issues long after the initial cancer diagnosis, according to a new study that found elevated rates of mental health-related doctor’s visits among family members up to 20 years later. Read more: https://www.theglobeandmail.com/canada/article-pediatric-cancer-can-affect-mental-health-of-patients-families-long/
- Nov 14, 2019
Researchers find new way to target childhood cancer
An international research effort has broken fresh ground in the race to find more effective treatments for the childhood cancer neuroblastoma, by uncovering a new and as-yet unexploited target in cancer cells that therapeutic drugs can be aimed at. Read more: https://www.sciencedaily.com/releases/2019/11/191112095750.htm
- Nov 14, 2019
Lithium can reverse radiation damage after brain tumor treatment
Children who have received radiotherapy for a brain tumour can develop cognitive problems later in life. In their studies on mice, researchers at Karolinska Institutet have now shown that the drug lithium can help to reverse the damage caused long after it has occurred. Read more: https://eurekalert.org/pub_releases/2019-11/ki-lcr111219.php#
- Nov 8, 2019
New molecule reduces the aggressiveness of pediatric cancer
A microRNA inhibitor identified by researchers at the FAPESP-supported Human Genome and Stem Cell Research Center reduced the sizes of aggressive tumors and improved survival in mice. Read more: https://www.eurekalert.org/pub_releases/2019-11/fda-nmr110719.php
- Nov 5, 2019
As children, they survived cancer. They faced the fallout as adults.
About one in every 600 young adults in the U.S. — 270,000 people aged 20 to 39 — is a cancer survivor, based on federal data. For most, the transition from pediatric to adult care is full of gaps and pitfalls. Read more: https://www.inquirer.com/health/childhood-cancer-survivors-radiation-treatment-michael-schiller-20191105.html
- Nov 5, 2019
Chemotherapy sometimes set the stage for drug-resistant leukemia at relapse
An international collaboration has identified therapy-induced, drug-resistance mutations in children with acute lymphoblastic leukemia who relapse. Read more: https://www.eurekalert.org/pub_releases/2019-11/sjcr-css110119.php#